OtherApr 9, 2026, 04:06 PM
LB Pharmaceuticals CEO Heather Turner to Present at 25th Annual Needham Virtual Healthcare Conference on April 16, 2026
AI Summary
LB Pharmaceuticals Inc (LBRX) announced that its Chief Executive Officer, Heather Turner, will present at the 25th Annual Needham Virtual Healthcare Conference. The presentation is scheduled for Thursday, April 16, 2026, at 11:45 a.m. ET. This event provides an opportunity for the company to engage with institutional investors and highlight its progress in developing novel therapies for neuropsychiatric diseases, including its lead product candidate, LB-102. A live webcast and archived replay of the presentation will be accessible on the company's investor relations website.
Key Highlights
- LB Pharmaceuticals CEO, Heather Turner, will present at the 25th Annual Needham Virtual Healthcare Conference.
- The presentation is scheduled for Thursday, April 16, 2026, at 11:45 a.m. ET.
- A live webcast and replay will be available on the 'Investors' page under the 'Events' section of the Company’s website at https://ir.lbpharma.us/investors/events/.
- LB Pharmaceuticals is a late-stage biopharmaceutical company focused on therapies for schizophrenia, bipolar depression, adjunctive MDD, and other neuropsychiatric diseases.
- The company's lead product candidate is LB-102, which it believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States.
Price Impact
More from LBRX